Deerfield Management’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$160M	Buy	35,606,974 +5,000,000	+16%	+$20M	1.89%	12
2025 Q4	$117M	Hold	30,606,974	–	–	1.49%	20
2025 Q3	$98.9M	Buy	30,606,974 +9,375,000	+44%	+$35.2M	1.52%	16
2025 Q2	$61.4M	Hold	21,231,974	–	–	1.11%	24
2025 Q1	$45.6M	Hold	21,231,974	–	–	0.9%	27
2024 Q4	$82.2M	Hold	21,231,974	–	–	1.56%	18
2024 Q3	$139M	Hold	21,231,974	–	–	2.08%	9
2024 Q2	$154M	Hold	21,231,974	–	–	2.56%	8
2024 Q1	$161M	Buy	21,231,974 +4,290,617	+25%	+$33.4M	2.8%	4
2023 Q4	$77.1M	Hold	16,941,357	–	–	1.42%	21
2023 Q3	$66.9M	Hold	16,941,357	–	–	1.47%	18
2023 Q2	$53M	Hold	16,941,357	–	–	1.13%	26
2023 Q1	$76.7M	Hold	16,941,357	–	–	1.71%	17
2022 Q4	$70M	Hold	16,941,357	–	–	1.45%	25
2022 Q3	$54.2M	Buy	16,941,357 +11,111,108	+191%	+$27.8M	1.08%	30
2022 Q2	$11.4M	Hold	5,830,249	–	–	0.24%	74
2022 Q1	$23.6M	Hold	5,830,249	–	–	0.53%	45
2021 Q4	$62.9M	Hold	5,830,249	–	–	1.32%	23
2021 Q3	$67.2M	Hold	5,830,249	–	–	1.31%	20
2021 Q2	$57.3M	Buy	5,830,249 +685,710	+13%	+$7.75M	1.02%	24
2021 Q1	$75.2M	Hold	5,144,539	–	–	1.58%	16
2020 Q4	$110M	Hold	5,144,539	–	–	2.18%	9
2020 Q3	$78M	Hold	5,144,539	–	–	1.9%	13
2020 Q2	$66.1M	Buy	+5,144,539	New	+$59.9M	1.93%	14
2016 Q3	–	Sell	-254,634	Closed	-$18.3M	–	98
2016 Q2	$18.3M	Hold	254,634	–	–	0.72%	48
2016 Q1	$20.4M	Buy	254,634 +184,329	+262%	+$14.6M	0.87%	41
2015 Q4	$5.31M	Buy	70,305 +24,182	+52%	+$3.88M	0.22%	79
2015 Q3	$17.7M	Sell	46,123 -37,845	-45%	-$17.1M	0.69%	53
2015 Q2	$34.9M	Sell	83,968 -3,547	-4%	-$1.48M	1.17%	27
2015 Q1	$41.6M	Buy	+87,515	New	+$41.5M	1.36%	18